1094-61-7 |
BETA-NICOTINAMIDE MONONUCLEOTIDE |
BETA-NMN;BETA-NICOTINAMIDE MONONUCLEOTIDE;BETA-NICOTINAMIDE RIBOSE MONOPHOSPHATE;NMN;NICOTINAMIDE-1-IUM-1-BETA-D-RIBOFURANOSIDE 5'-PHOSPHATE;NICOTINAMIDE RIBOTIDE;NICOTINAMIDE MONONUCLEOTIDE;3-(aminocarbonyl)-1-(5-O-phosphonato-beta-D-ribofuranosyl)pyridinium |
C11H15N2O8P |
57
supplier(s) 1094-61-7 |
183319-69-9 |
Erlotinib hydrochloride |
ERLOTINIB HCL;ERLOTINIB HCL SALT;ERLOTINIB HCL SALT :TARCEVA;Erlotinib, Hydrochloride Salt;N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine, Hydrochloride Salt, OSI 774, Tarceva;N-(3-Ethynylphenyl)-6,7-bis-(2-methoxyethoxy)-quinazolin-4-amine;[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4yl]-(3-ethynyl-phenyl)-amine;Tarceva HydrochlorideSee E625000 |
C22H24ClN3O4 |
19
supplier(s) 183319-69-9 |
1317-38-0 |
Cupric oxide |
Banacobru OL;C.I. Pigment Black 15;Chrome Brown;Copper monooxide;Copper oxide (CuO);Copperoxide(CuO);CuO;Precipitated cupric oxide |
CuO |
6
supplier(s) 1317-38-0 |
134678-17-4 |
Lamivudine |
(-)-BCH-189;(-)-BETA-L-2',3'-DIDEOXY-3'-THIACYTIDINE;(-)-B-L-2',3'-DIDEOXY-3'-THIACYTIDINE;(2r-cis)-4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1h)-pyrimidinone;2'-deoxy-3'-thiacytidine;4-AMINO-1-((2R,5S)-2-HYDROXYMETHYL-[1,3]OXATHIOLAN-5-YL)-1H-PYRIMIDIN-2-ONE;3TC;3'-THIA-2',3'-DIDEOXYCYTIDINE |
C8H11N3O3S |
19
supplier(s) 134678-17-4 |
107-95-9 |
beta-Alanine |
3-Aminopropanoic acid; b-Alanine,(3-Aminopropionic acid); 3-aminopropionic acid; H-BAla-OH; H-beta-Ala-OH~3-Aminopropionic acid; β-Alanine-14C; beta-aminopropionic acid; beta-Alanine; 3-Aminopropanoic acid; β-Aminopropionic acid; H-β-Ala-OH; β-Ala |
C3H7NO2 |
13
supplier(s) 107-95-9 |
1013916-37-4 |
2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one |
2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one;Pyrido[2,3-d]pyriMidin-7(8H)-one, 2-chloro-8-cyclopentyl-5-Methyl- |
|
7
supplier(s) 1013916-37-4 |
147526-32-7 |
Pitavastatin calcium |
(+)-Monocalciumbis{(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptenoate}; calcium bis{(1R,3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-1,3,5-trihydroxyhept-6-en-1-olate}; (+)-Monocalciumbis{(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-,5-dihydroxy-6-heptenoate} |
C50H48CaF2N2O8 |
19
supplier(s) 147526-32-7 |
128-13-2 |
Ursodeoxycholic acid |
3,7-Dihydroxycholan-24-oic acid; 3alpha,7beta-Dihydroxy-6beta-cholan-24-oic acid; Ursodiol; 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethanol; (3alpha,5beta,7alpha)-3,7-dihydroxycholan-24-oic acid; (3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid; (4R)-4-[(3R,5S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid; (4R)-4-[(3R,5S,7S,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid; (3alpha,5beta,7beta,8xi,9xi,14xi)-3,7-dihydroxycholan-24-oic acid; (3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oate; (3alpha,5alpha,7beta)-3,7-dihydroxycholan-24-oate |
C24H39O4 |
46
supplier(s) 128-13-2 |
134523-03-8 |
Atorvastatin Calcium |
ATORVASTATIN CA; [r-(r*, r*)]-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylaminocarbonyl)-1h-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid calcium salt; 1h-pyrrole-1-heptanoicacid,beta,delta-dihydroxy-2-(4-fluorophenyl)-5-(1-methy calciumsalt(2:1),(r-(r*,r*))-lethyl)-3-phenyl-4-((phenylamino)carbonyl); delta-dihydroxy-2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-betcalci1h-pyrrole-1-heptanoicaci; pd134298-38a; ATORVASTATINCALCUIM; calcium (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-p ropan-2-yl-pyrrol-1-yl]-3,5-dihydroxy-heptanoate; 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-beta,delta-dihydroxy-5 -(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-calcium salt (2: 1), (R-(R*,R*))-; 1H-Pyrrole-1-heptanoic acid; beta,delta-dihydroxy-2-(4-fluorophenyl)-5 -(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-calcium salt (2: 1); (R-(R*,R*))-, Atorvastatin calcium; Atorvastatin calcium (USAN); Atorvastatin calcium salt; Atorvastatin calcium [USAN]; C08078; Calcium (betaR,deltaR)-2-(p-fluorophenyl)-beta,delta-dihydroxy-5-isopr opyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoate (1:2); CI-981; D00887; DRG-0321; Lipibec; Lipitor; Lipitor (TN); LS-136974; PD 134298-38A; Prevencor; Sortis; Tahor; Torvast; YM-548; Atorvastatin Calsium; (3R,5R)-7-[2-(4-Fluorophenyl)-5-Isopropyl-3-Phenyl-4-(Pheynylcarbamoyl)Pyrrol-1-yl]-3,5-Dihydroheptanoic Acid,calcium salt; (3R,5R)-7-[2-(4-Fluorophenyl)-5-Isopropyl-3-Phenyl-4-(Pheynylcarbamoyl)Pyrrol-1-yl]-3,5_Dihydroheptanoic Acid,calcium salt |
C66H68Ca2F2N4O10 |
28
supplier(s) 134523-03-8 |
1405-41-0 |
Gentamycin Solution |
gentamicin solution 10mg/ml sterile*filtered; gentamicin standard solution; gentamicin sulfate from micromonospora purpurea; gentamicin sulfate cell culture tested; gentamicin solution cell culture tested; gentamicin sulfate solution hybri-max*50mg/ml; Gentamicin sulfate, USP Grade; Gentamicin sulfate Micromonospora purpurea; gentamicin sulphate; Gentamycin sulfate; Gentamycin Sulphate; GENTAMICIN 2,5-SULFATE HYDRATE; genoptics.o.p.; gentalline; gentamicinsolution; nsc-82261; sch9724; Gentamicin Sulfate; 4,6-diamino-3-{[3-deoxy-4-C-methyl-3-(methylamino)pentopyranosyl]oxy}-2-hydroxycyclohexyl 2-amino-2,3,4,6,7-pentadeoxy-6-(methylamino)heptopyranoside |
C19H41N5O11S |
31
supplier(s) 1405-41-0 |